GSK position history
The shares of GSK that Hillman Capital Management, Inc. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2022 Q3: 243,978 shares, $7.2M, 3.0% of portfolio, New
- 2022 Q4: 237,879 shares, $8.4M, 3.3% of portfolio, Reduce −2.5%
- 2023 Q1: 237,416 shares, $8.4M, 3.2% of portfolio, Reduce −0.2%
- 2023 Q2: 234,681 shares, $8.4M, 3.0% of portfolio, Reduce −1.2%
- 2023 Q3: 232,864 shares, $8.4M, 3.2% of portfolio, Reduce −0.8%
- 2023 Q4: 233,386 shares, $8.6M, 3.0% of portfolio, Add +0.2%
- 2024 Q1: 233,486 shares, $10M, 3.2% of portfolio, Add 0.0%
- 2024 Q2: 195,126 shares, $7.5M, 2.7% of portfolio, Reduce −16.4%
- 2024 Q3: 196,896 shares, $8M, 2.8% of portfolio, Add +0.9%
- 2024 Q4: 231,151 shares, $7.8M, 2.9% of portfolio, Add +17.4%
- 2025 Q1: 165,143 shares, $6.4M, 3.1% of portfolio, Reduce −28.6%
- 2025 Q2: 152,599 shares, $5.9M, 3.2% of portfolio, Reduce −7.6%
- 2025 Q3: 141,779 shares, $6.1M, 3.6% of portfolio, Reduce −7.1%
- 2025 Q4: 114,336 shares, $5.6M, 3.5% of portfolio, Reduce −19.4%
- 2026 Q1: 97,432 shares, $5.4M, 3.7% of portfolio, Reduce −14.8%
- 2026 Q2: 92,383 shares, $4.8M, 3.5% of portfolio, Reduce −5.2%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|